Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Discriminating promiscuous from target‐specific autoantibodies in COVID‐19

1 Mar 2023

Abstract excerpt

Diverse autoantibodies were suggested to contribute to severe outcomes of COVID-19, but their functional implications are largely unclear. ACE2, the SARS-CoV-2 receptor and a key regulator of blood pressure, was described to be one of many targets of autoantibodies in COVID-19. ACE2 in its soluble form (sACE2) is highly elevated in the blood of critically ill patients, raising the question of whether sACE2:spike...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Complement system in diseases
Share to COVID-19 Clinical Research Studies
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36856018
DOI: 10.1002/eji.202250210

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 10 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Discriminating promiscuous from target‐specific autoantibodies in COVID‐19PMID 36856018Read ↗

Autoantibodies Targeting Angiotensin Converting Enzyme 2 Are Prevalent and Not Induced by SARS-CoV-2 InfectionSemantic proximity Read ↗

Predominance of Distinct Autoantibodies in Response to SARS-CoV-2 InfectionSemantic proximity Read ↗

ACE2 expression in PBMC and plasma markers of vasculopathy and fibrosis during early COVID – implications for post-COVID conditionsSemantic proximity Read ↗

Differential expression in humans of the viral entry receptor ACE2 compared with the short deltaACE2 isoform lacking SARS-CoV-2 binding sitesSemantic proximity Read ↗

Autoimmunity in long COVIDSemantic proximity Read ↗

Emerging roles of SARS-CoV-2 Spike-ACE2 in immune evasion and pathogenesisSemantic proximity Read ↗

Evaluation of miR-200c-3p and miR-421-5p levels during immune responses in the admitted and recovered COVID-19 subjectsSemantic proximity Read ↗

Diverse Functional Autoantibodies in Patients with COVID-19Semantic proximity Read ↗

COVID-19 patient serum less potently inhibits ACE2-RBD binding for various SARS-CoV-2 RBD mutantsSemantic proximity Read ↗

ACE2, COVID19 and serum ACE as a possible biomarker to predict severity of diseaseSemantic proximity Read ↗

Deciphering the IgG Idiotype Network Through Proteomic Analysis of Potential Targets in SARS ‐ CoV ‐2‐Induced Immune ResponsesSemantic proximity Read ↗

SARS-CoV-2 Spike Protein-Directed Monoclonal Antibodies May Ameliorate COVID-19 Complications in APECED Patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.